QQ客服 官方微博 反馈留言

	An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report
	Chen, Chun-yan; Zhao, Chong; Gao, Li; Lang, Jin-yi; Pan, Jian-ji; Hu, Chao-su; Jin, Feng; Wang, Ren-sheng; Xie, Conghua; Lin, Tongyu
	2012
卷号	30期号:15
ISSN号	0732-183X
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6707153
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Chen, Chun-yan,Zhao, Chong,Gao, Li,et al. An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report[J],2012,30(15).
APA	Chen, Chun-yan.,Zhao, Chong.,Gao, Li.,Lang, Jin-yi.,Pan, Jian-ji.,...&Lu, Tai-xiang.(2012).An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report.,30(15).
MLA	Chen, Chun-yan,et al."An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report".30.15(2012).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。